Quantum Pharmaceutical Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Quantum Pharmaceutical Limited - overview
Established
2004
Location
-, Durham, UK
Primary Industry
Pharmaceuticals
About
Quantum Pharmaceutical Limited is a UK-based specialist pharmaceutical company focused on providing innovative, tailored solutions for the healthcare sector, enhancing operational efficiency and user experience. Founded in 2004 and headquartered in the UK, Quantum Pharmaceutical Limited specializes in the development of pharmaceutical products. The company went public through an IPO in December 2014, raising GBP 106. 1 mn.
The firm has completed two significant deals to date, with its latest funding round being the IPO in 2014 which raised funds through the sale of 106. 1 million shares at GBP 1 each. Quantum Pharmaceutical Limited offers innovative pharmaceutical solutions designed to meet the specific needs of healthcare providers. Their products enhance operational efficiency and user experience across various sectors, targeting end use cases such as process streamlining and effective communication.
With a client base spanning North America, Europe, and parts of Asia, the company caters to both established enterprises and emerging startups seeking advanced pharmaceutical technologies. In the most recent financial year 2023, Quantum Pharmaceutical Limited reported a revenue of GBP 217,482,940. 2, with an EBITDA of GBP 22,325,826. 9.
The company's revenue model combines direct-to-consumer sales with B2B partnerships, primarily leveraging subscription models for ongoing access to its flagship pharmaceutical products, while fostering strategic partnerships that broaden its market reach. Quantum Pharmaceutical Limited plans to expand its product line with upcoming innovations set to launch in the next year, aiming to enhance their service offerings. The company is also targeting new markets for expansion, focusing on regions within Asia and Europe by 2025. The capital raised during their IPO in December 2014, amounting to GBP 106.
1 mn, will be utilized to support these growth initiatives.
Current Investors
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Website
www.quantum-specials.co.uk
Company Stage
Mature
Total Amount Raised
Subscriber access only
Quantum Pharmaceutical Limited - timeline of key events
Quantum Pharmaceutical Limited - financials
| Fiscal Year Ended | Jan 31, 2010 | Jan 31, 2011 | Jan 31, 2012 | Jan 31, 2013 | Jan 31, 2014 | Jan 31, 2015 | Jan 31, 2016 | Jan 31, 2017 | Jun 30, 2018 | Jun 30, 2019 | Jun 30, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | 35,023,000 | 33,371,000 | 35,199,000 | 40,990,000 | 47,337,000 | 47,502,000 | 51,351,000 | 76,092,000 | 52,699,000 | 60,980,000 | 120,339,373 | - | - | - |
| % Revenue Growth (YoY) | - | - | (4.7%) | 5.5% | 16.5% | 15.5% | 0.3% | 8.1% | - | - | 15.7% | - | - | - | - |
| EBITDA (USD) | 7,514,000 | 11,163,000 | 9,220,000 | 8,006,000 | 6,639,000 | 5,790,000 | 7,907,000 | (9,166,000) | (7,187,000) | 1,261,000 | (8,843,000) | 3,449,706 | - | - | - |
| Operating Income (USD) | 7,265,000 | 10,866,000 | 8,886,000 | 7,606,000 | 6,273,000 | 5,311,000 | 7,221,000 | (10,048,000) | (8,241,000) | 703,000 | (9,588,000) | 2,489,568 | - | - | - |
| Operating Margin | - | 31.0% | 26.6% | 21.6% | 15.3% | 11.2% | 15.2% | (19.6%) | (10.8%) | 1.3% | (15.7%) | 2.1% | - | - | - |
| % EBITDA Margin | - | 31.9% | 27.6% | 22.7% | 16.2% | 12.2% | 16.6% | (17.8%) | (9.4%) | 2.4% | (14.5%) | 2.9% | - | - | - |
| NET Income (USD) | 5,145,000 | 7,803,000 | 7,036,000 | 4,593,000 | 7,313,000 | 4,785,000 | 6,567,000 | (10,861,000) | (8,345,000) | 84,000 | (9,982,000) | 15,443,825 | - | - | - |
| % Net Margin | - | 22.3% | 21.1% | 13.0% | 17.8% | 10.1% | 13.8% | (21.2%) | (11.0%) | 0.2% | (16.4%) | 12.8% | - | - | - |
Quantum Pharmaceutical Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPO | Completed | Quantum Pharmaceutical Limited | - | ||||||||
| Buyout | Completed | Quantum Pharmaceutical Limited | - |
Displaying 1 - 2 of 2
Quantum Pharmaceutical Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.